These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10768092)

  • 1. Glycation impairs high-density lipoprotein function.
    Hedrick CC; Thorpe SR; Fu MX; Harper CM; Yoo J; Kim SM; Wong H; Peters AL
    Diabetologia; 2000 Mar; 43(3):312-20. PubMed ID: 10768092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
    Sanguinetti SM; Brites FD; Fasulo V; Verona J; Elbert A; Wikinski RL; Schreier LE
    Diabetes Nutr Metab; 2001 Feb; 14(1):27-36. PubMed ID: 11345163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.
    Van Lenten BJ; Hama SY; de Beer FC; Stafforini DM; McIntyre TM; Prescott SM; La Du BN; Fogelman AM; Navab M
    J Clin Invest; 1995 Dec; 96(6):2758-67. PubMed ID: 8675645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High density lipoprotein and low density lipoprotein attenuate the inhibitory effects of oxidized low density lipoprotein on endothelium-dependent arterial relaxation.
    Matsuda Y
    Kobe J Med Sci; 1993 Feb; 39(1):1-14. PubMed ID: 8366661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized low-density lipoproteins stimulate adhesion of monocytes to endothelial cells.
    Niu XL; Yan XD; Guo ZG
    Zhongguo Yao Li Xue Bao; 1997 Jan; 18(1):59-62. PubMed ID: 10072896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
    Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
    J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of high density lipoprotein (HDL) in promoting monocytic adhesion to and migration into the arteria intima].
    Wang Z
    Zhonghua Yi Xue Za Zhi; 1991 Aug; 71(8):446-9. PubMed ID: 1660766
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease.
    Kalogerakis G; Baker AM; Christov S; Rowley KG; Dwyer K; Winterbourn C; Best JD; Jenkins AJ
    Clin Sci (Lond); 2005 Jun; 108(6):497-506. PubMed ID: 15634192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deleterious effect of glycation on the ability of HDL to counteract the inhibitory effect of oxidized LDL on endothelium-dependent vasorelaxation.
    Brindisi MC; Duvillard L; Monier S; Vergès B; Perségol L
    Diabetes Metab Res Rev; 2013 Nov; 29(8):618-23. PubMed ID: 23908137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycated high-density lipoprotein induces apoptosis of endothelial cells via a mitochondrial dysfunction.
    Matsunaga T; Iguchi K; Nakajima T; Koyama I; Miyazaki T; Inoue I; Kawai S; Katayama S; Hirano K; Hokari S; Komoda T
    Biochem Biophys Res Commun; 2001 Sep; 287(3):714-20. PubMed ID: 11563854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin-1 plus oxidized low-density lipoprotein, but neither alone, increase human monocyte adhesion to endothelial cells.
    Langenfeld MR; Nakhla S; Death AK; Jessup W; Celermajer DS
    Clin Sci (Lond); 2001 Dec; 101(6):731-8. PubMed ID: 11724663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-density-lipoprotein (LDL)-bound flavonoids increase the resistance of LDL to oxidation and glycation under pathophysiological concentrations of glucose in vitro.
    Wu CH; Lin JA; Hsieh WC; Yen GC
    J Agric Food Chem; 2009 Jun; 57(11):5058-64. PubMed ID: 19489629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low density lipoprotein-apheresis decreases oxidized low density lipoproteins and monocyte adhesion to endothelial cells.
    Cattin L; Petrucco A; Cazzolato G; Bon GB; Borelli V; Nardon E; Zabucchi G; Fonda M; Bordin P
    ASAIO J; 1997; 43(3):209-13. PubMed ID: 9152493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycation of human high density lipoprotein by methylglyoxal: effect on HDL-paraoxonase activity.
    Bacchetti T; Masciangelo S; Armeni T; Bicchiega V; Ferretti G
    Metabolism; 2014 Mar; 63(3):307-11. PubMed ID: 24360750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD36 is a receptor for oxidized high density lipoprotein: implications for the development of atherosclerosis.
    Thorne RF; Mhaidat NM; Ralston KJ; Burns GF
    FEBS Lett; 2007 Mar; 581(6):1227-32. PubMed ID: 17346709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients.
    Cai W; He JC; Zhu L; Peppa M; Lu C; Uribarri J; Vlassara H
    Circulation; 2004 Jul; 110(3):285-91. PubMed ID: 15249511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation.
    Choudhury RP; Rong JX; Trogan E; Elmalem VI; Dansky HM; Breslow JL; Witztum JL; Fallon JT; Fisher EA
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1904-9. PubMed ID: 15319266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.